This is not a TV series: the billionaire who appointed his children to senior positions in the empire he built

A billionaire father, who has built himself with both hands, appoints his children to senior positions in his business empire only to keep them away after a few years – because he is not happy with their performance. It may sound like a TV script, but these are the events of recent years in the insurance company responsible for the pension future of about 2 million Israelis. Everything you need to know – join TheMarker’s telegram channel (download – on Android, iPhone) In March 2012, businessman Shlomo Eliyahu caused a stir in the Israeli capital market. In the Bezeq deal, he acquired control of Migdal Insurance from the Italian company Generali for NIS 4.2 billion. Elijah marked a goal and within a month closed the deal. On the obstacle – obtaining a certificate of control of an insurance company —…

Comments Skip the comments

Thanks!

Your response has been successfully received , and will be published according to the system policy

You can receive an email notification when your response is approved and published.

Thank you!

Your response was successfully received, And will be published according to the system’s policy

Please try again in a timely manner Later

    )) Arrange the comments

    Main Articles on the Site

    Note: This article has been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Analysts Point to Returning “Appetite” for Bitcoin Amid Change in Market Sentiment thumbnail

Analysts Point to Returning “Appetite” for Bitcoin Amid Change in Market Sentiment

Bitcoin has repeatedly failed to breach the US$65K mark, indicating a potential resistance level. Santiment analysts observe capital moving from Bitcoin to altcoins, seeking higher yields. Significant drops in Bitcoin open interest suggest traders anticipate a market peak and are selling. Bitfinex notes increased risk appetite and potential interest rate cuts following Powell’s speech. Bitcoin
Read More
Outside the Box: Debt gets a bad rap. As a college president, I’ve seen how loans have helped lower-income students the most thumbnail

Outside the Box: Debt gets a bad rap. As a college president, I’ve seen how loans have helped lower-income students the most

Many commentators have applauded President Biden’s recent move to cancel up to $20,000 of student debt for low- to middle-income borrowers. One unintended side effect, however, has been a souring of public sentiment on student loans. If the government has to step in and bail out students, the thinking goes, that must mean that student debt
Read More
HBR’s Most-Read Research Articles of 2021 thumbnail

HBR’s Most-Read Research Articles of 2021

What will it take to make work better? Over the past year, HBR has published a wide array of research-backed articles that explore topics ranging from retaining employees to overcoming meeting overload to fostering gender equity in the workplace. In this end-of-year roundup, we share key insights and trends from our most-read research articles of…
Read More
Bitcoin and Ethereum Consolidate Gains, DOGE and SHIB Surge thumbnail

Bitcoin and Ethereum Consolidate Gains, DOGE and SHIB Surge

Bitcoin price is consolidating below the USD 44,000 resistance.Ethereum is stable above USD 3,300, XRP still below USD 0.80.DOGE and SHIB gained over 10%.Bitcoin price spiked above the USD 44,000 level before starting a downside correction. BTC traded below the USD 43,600 level. It is currently (12:21 PM UTC) consolidating gains near USD 43,900 and…
Read More
Lupin divests women's health specialty biz in US thumbnail

Lupin divests women’s health specialty biz in US

Global pharma major Lupin announced on Monday that it has divested its US commercial women’s health specialty business to Evofem Biosciences, a US biopharmaceutical company focused exclusively on women’s health.Lupin’s US Commercial Women’s Health Specialty Business is primarily focused on commercializing Solosec (secnidazole) 2g oral granules. This FDA-approved single-dose antimicrobial agent provides a complete course
Read More
Index Of News
Total
0
Share